Prostate Cancer
Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer.
January 12, 2024
Non-invasive detection of neuroendocrine prostate cancer through targeted cell-free DNA methylation.
January 12, 2024
Genomic classifiers and prognosis of localized prostate cancer: a systematic review.
January 12, 2024
Clinical Positron Emission Tomography/Computed Tomography: Quarter-Century Transformation of Prostate Cancer Molecular Imaging.
January 12, 2024
Radiation Therapy Summary of the AUA/ASTRO Guideline on Clinically Localized Prostate Cancer.
January 11, 2024
Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy?
January 11, 2024
Adaption and National Validation of a Tool for Predicting Mortality from Other Causes Among Men with Nonmetastatic Prostate Cancer.
January 11, 2024
Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer.
January 10, 2024
Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients.
January 10, 2024
A population-based study of cardiovascular disease mortality risk in US cancer patients.
January 10, 2024
Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC.
January 10, 2024
Assessment of Cell Surface Targets in Metastatic Prostate Cancer: Expression Landscape and Molecular Correlates.
January 10, 2024